Effective Second-Line Treatment for Mesothelioma Gaining Ground
Doctors at the Swiss Group for Clinical Cancer Research in Zurich, Switzerland, have uncovered a novel, anti-tumor compound that could become a needed second-line treatment for pleural mesothelioma cancer. Their recent multicenter phase II clinical trial conducted in Switzerland and Italy revealed the safety and efficacy of lurbinectedin, a synthetically produced agent that inhibits the growth of mesothelioma cells. “We believe this could represent a new treatment option for pleural mesothelioma,” Dr. Yannis Metaxas, oncologist at Kantonsspital Graubunden outside Zurich, told The Mesothelioma Center at Asbestos.com. ...
Source: Asbestos and Mesothelioma News - October 17, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

A New Study Suggests Tainted Talcum Powder Can Cause a Rare Cancer. Here ’s How That Could Play Out in the Courtroom
A new 33-patient case study published in the Journal of Occupational and Environmental Medicine provides some of the strongest proof yet that exposure to asbestos-tainted talcum powder may cause malignant mesothelioma, a rare and deadly cancer that affects tissues lining internal organs. This isn’t only an important scientific discovery—it could also give new ammunition to plaintiffs in the thousands of cases brought against brands selling talcum-powder-based products alleged to cause cancer, like Johnson & Johnson’s Baby Powder. “It’s very, very hard, in general, to prove exactly what cau...
Source: TIME: Health - October 15, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Environmental Health HealthSummit19 Research toxins Source Type: news

New York ’s MTA Ignored Asbestos Dangers for Years
Glaring safety issues involving asbestos exposure within the Metropolitan Transportation Authority extend further than the East New York bus depot in Brooklyn, a report from the agency’s inspector general alleges. Inhaling or ingesting tiny asbestos fibers in the air can lead to serious health conditions later in life, including mesothelioma cancer. The inspector general report, released Monday, shows MTA managers ignored asbestos safety concerns at bus and train facilities across New York City for years. Asbestos-containing materials were found in disrepair in the boiler rooms of at least six MTA depots throughout the...
Source: Asbestos and Mesothelioma News - October 8, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Keytruda for Mesothelioma Flops in Phase III Clinical Trial
Results from a phase III clinical trial comparing Keytruda (pembrolizumab) to standard chemotherapy shows the immunotherapy drug still has a long way to go as a viable treatment option for malignant pleural mesothelioma. Keytruda did not improve progression-free survival for mesothelioma patients who progressed after first-line chemotherapy. The disappointing results from the PROMISE-meso study were presented at the European Society of Medical Oncology (ESMO) annual meeting last week. It was the first randomized trial comparing progression-free survival between immunotherapy and first-line chemotherapy for mesothelioma p...
Source: Asbestos and Mesothelioma News - October 7, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Idaho woman wins $40 million in lawsuit over baby powder-linked cancer
A California jury has awarded Nancy Cabibi, 71, over $40 million after alleging she developed mesothelioma from using Johnson & Johnson's baby powder, which contains the carcinogen, asbestos. (Source: the Mail online | Health)
Source: the Mail online | Health - October 1, 2019 Category: Consumer Health News Source Type: news

First Mesothelioma Patient Begins Newly Approved Treatment
A mesothelioma patient at West Cancer Center in Memphis, Tennessee, is the first in the country to use NovoTTF-100L, a noninvasive electric therapy treatment, since its approval by the U.S. Food and Drug Administration in May. The FDA’s approval of Novocure’s Tumor Treating Fields device for the treatment of mesothelioma marked the first new FDA-approved treatment option for the rare asbestos-related cancer in more than 15 years. NovoTTF-100L uses a low-voltage electrical field that is distributed with three pads attached to the front and back of a person’s chest. The electrical current is designed to disrupt th...
Source: Asbestos and Mesothelioma News - October 1, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Disappointment Over Immunotherapy in Mesothelioma Disappointment Over Immunotherapy in Mesothelioma
Despite achieving better response rates in the second-line treatment of malignant pleural mesothelioma, pembrolizumab did not improve survival over chemotherapy in a phase 3 trial.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 30, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Inspector General Report: Asbestos Exposure a Concern on Army Posts
Residents in privatized housing on nearly 50 Army installations cited concerns with issues such as lead paint and asbestos, the toxic building material linked to mesothelioma cancer, according to a recent report from the Department of the Army Inspector General. The report, which was made public earlier this month, includes surveys, document reviews and interviews with residents at 49 Army installations across the U.S., including Fort Bragg (N.C.), Fort Campbell (Ky.) and Fort Hood in Texas. Military families at 48 of the 49 sites cited concerns with safety or environmental issues inside the aging on-base housing at the ...
Source: Asbestos and Mesothelioma News - September 25, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

How Slow Moving Asbestos Regulations Compromise Health
By Sarah WolvertonWALLINGFORD, CT, US, Sep 24 2019 (IPS) Last year, the United States introduced a new asbestos rule that was received both positively and negatively and Canada banned the mineral altogether. Countries like the U.K. and Australia continue to struggle with the health implications of historic asbestos use, despite both having bans for several years. In contrast, nations like Russia and Vietnam continue to manufacture and use the mineral frequently.  Asbestos is a substance that was used throughout history as an additive in many products to provide heat and fire resistance. It fell out of favor around the wor...
Source: IPS Inter Press Service - Health - September 24, 2019 Category: International Medicine & Public Health Authors: Sarah Wolverton Tags: Development & Aid Environment Headlines Health Source Type: news

Medicare Now Covers CAR T-Cell Therapy for Approved Cancers
A promising and expensive type of immunotherapy, called CAR T-cell therapy, is now covered by Medicare. This news may affect mesothelioma patients in the future. Chimeric antigen receptor T-cell, or CAR T-cell, therapy involves the laboratory reprogramming of a patient’s T cells, which are a type of white blood cell responsible for protecting the body against infection and disease. The T cells are genetically modified to better recognize and attack cancer. The U.S. Food and Drug Administration has approved the immunotherapy procedure for non-Hodgkin lymphoma and B-cell precursor acute lymphoblastic leukemia. It is sti...
Source: Asbestos and Mesothelioma News - September 19, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Mesothelioma Cells Slowed by Grape-Seed Extracts
Extracts from two Italian grape varieties showed distinct anti-cancer activity in three different mesothelioma cell lines, according to a recent multicenter study in Naples, Italy. The in-vitro findings strongly suggest potential of a novel, nonconventional mesothelioma treatment advancement in the future for this aggressive, difficult-to-treat cancer. Previous laboratory studies have shown a negative impact of grape-seed extracts on breast, colon and skin cancer cells, but this was the first using multiple human mesothelioma cell lines. “Our study on mesothelioma seems very promising, but it is a preliminary analysis,...
Source: Asbestos and Mesothelioma News - September 12, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Asbestos in Makeup Leads to Recall of City Color Products
Beauty Plus Global Inc., the cosmetics and packaging manufacturer behind City Color and Max Mell, has issued a voluntary recall of four City Color makeup products that tested positive for asbestos contamination. The U.S. Food and Drug Administration announced the recall Friday in the agency’s latest advisory regarding asbestos-contaminated cosmetics. The four recalled City Color products include: Beauty Plus Global Inc. City Color Collection Matte Blush (Fuchsia) — SKU #849136008807, Lot No. 1605020/PD-840 Beauty Plus Global Inc. City Color Cosmetics Timeless Beauty Palette — SKU #849136012958, Lot No. 151...
Source: Asbestos and Mesothelioma News - September 9, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Mesothelioma Clinical Trial Targets Latest Gene Therapy
Pioneering pulmonologists Dr. Steven Albelda and Dr. Daniel Sterman have worked for more than 20 years on developing gene therapy to effectively combat pleural mesothelioma cancer. The payoff may have finally arrived. Albelda and Sterman’s long-awaited, phase III clinical trial will open this month to evaluate the efficacy of TR002, a novel gene therapy drug, when used in combination with celecoxib and gemcitabine. TR002, a form of immunotherapy, is a genetically engineered adenovirus that triggers the anti-tumor effects of interferon, a naturally occurring protein that destroys cancer cells. “The hope is, if it works ...
Source: Asbestos and Mesothelioma News - September 4, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

St. Louis auto mechanic wins $8M verdict for asbestos exposure
A St. Louis auto mechanic won $8.4 million against Ford Motor Co. for asbestos exposure in the 1960s, ‘70s and ‘80s while working at its dealerships. The mechanic, Al Bennett, and his wife, Pam Bennett, were represented by Chris Layloff and Jason Steinmeyer of the Gori Law Firm, who argued that he was exposed to asbestos through regular contact with brakes, gaskets, clutches and replacement par ts, leading to pleural mesothelioma diagnosis in his right lung. Now retired, Bennett continues to… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 30, 2019 Category: Biotechnology Authors: Greg Edwards Source Type: news

St. Louis auto mechanic wins $8M verdict for asbestos exposure
A St. Louis auto mechanic won $8.4 million against Ford Motor Co. for asbestos exposure in the 1960s, ‘70s and ‘80s while working at its dealerships. The mechanic, Al Bennett, and his wife, Pam Bennett, were represented by Chris Layloff and Jason Steinmeyer of the Gori Law Firm, who argued that he was exposed to asbestos through regular contact with brakes, gaskets, clutches and replacement par ts, leading to pleural mesothelioma diagnosis in his right lung. Now retired, Bennett continues to… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 30, 2019 Category: Pharmaceuticals Authors: Greg Edwards Source Type: news